The North American synthetic biology market is anticipated to grow at a CAGR of 31.0% during the forecast period. The market growth is attributed to the increasing demand for bio-based products, rising R&D funding for synthetic biology, and increased investments by synthetic biology companies. Further, the growing support from the government, private institutions, and increasing R&D investments in the development of the drugs are other major factors that are expected to drive the North American synthetic biology market growth during the forecast period.  

Visit for Global Synthetic Biology Market Report at: https://www.omrglobal.com/industry-reports/synthetic-biology-market-size

Furthermore, technological advancements in the life science sector have resulted in increased speed and reduced cost of DNA amalgamation. This enables researchers to design and integrate adjusted bacterial chromosomes that can be utilized as a part of the generation of cutting-edge biofuels, bio-items, sustainable chemicals, and others. The advancements in modern engineering have enabled scientists to build new sequences of DNA. 

The North American synthetic biology market is segmented on the basis of product, technology, and applications. Based on the product, the market is segmented into enabling products, core products, and enabled products. Core product includes synthetic genes, synthetic cells, synthetic DNA, chassis organisms and Xeno Nucleic Acid (XNA), and are expected to hold a significant share in the market owing to extensive use of core products in R&D. Based on technology, the market is segmented into, and gene synthesis & sequencing, genome engineering, bioinformatics, and others. Based on application, the market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications.

The North American synthetic biology industry includes the competitive analysis of various players include Twist Bioscience Corp., Merck KGaA, GenScript Biotech Corp., Thermo Fisher Scientific Inc., Amyris Inc., Codexis Inc, and many others. These players are focusing on agreements along with new product launches for expanding their business. In 2017, Thermo Fisher Scientific, Inc. established a collaboration with AstraZeneca and offered its CRISPR Technology to AstraZeneca’s entire drug discovery platform.

Research Methodology

The market study of the North American synthetic biology is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report is intended for pharmaceutical companies, drug manufacturers, biotechnology companies, chemical, and biofuel industry, academic and government research institutes, food and agriculture industries, potential investors and venture capitalists, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, products offered by the company, and future market opportunities. The report will serve as a source for a 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. North American Synthetic Biology Market Research and Analysis by Product

2. North American Synthetic Biology Market Research and Analysis by Technology

3. North American Synthetic Biology Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the North American synthetic biology market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American synthetic biology market.
• Insights about market determinants which are stimulating the North American synthetic biology market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.